The potential of TB treatment 8 weeks

Published Date: 08 Mar 2023

While some say this strategy's failure rate is "too high," it's one step closer to the "white grail" of a shorter 24-week formula.

Read Full News

Latest News

US Supreme Court Lets Abortion Pill Mail Delivery Continue

The U.S. Supreme Court on Thursday ensured that the abortion pill can continue to be prescribed through telemedicine and dispensed by mail, as the justices restored for now...

Real-World Data Support Maribavir for Posttransplant CMV

Maribavir is an effective and well-tolerated option for cytomegalovirus infection and disease among hematopoietic cell transplant recipients.

Biomarkers Spot Invasive Aspergillosis Post-Lung Transplant

RNA testing may help assess the consequences of common environmental mold.

South Africa: Brit With Hantavirus Gradually Improving

The condition of a British man who was admitted ⁠to a hospital in Johannesburg after falling ill with hantavirus aboard ⁠a luxury cruise ship is gradually improving.

Pregnancy vs Postpartum Flare Rates Differ in RA and SpA

Patients with rheumatoid arthritis are more likely to experience flares during the early postpartum period than during pregnancy; however, flare rates in those with spondyloarthritis remain stable.

WHO Says Seven Cases Of Hantavirus Confirmed From Cruise Ship

Seven cases of the ⁠Andes hantavirus have now been confirmed among people ⁠who were passengers on board the ⁠cruise ship, the ‌World Health Organization said on...

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Latest News

The U.S. Supreme Court on Thursday ensured that the abortion pill can continue to be prescribed through telemedicine and dispensed by mail, as the justices restored for now...

Maribavir is an effective and well-tolerated option for cytomegalovirus infection and disease among hematopoietic cell transplant recipients.

RNA testing may help assess the consequences of common environmental mold.

The condition of a British man who was admitted ⁠to a hospital in Johannesburg after falling ill with hantavirus aboard ⁠a luxury cruise ship is gradually improving.

Patients with rheumatoid arthritis are more likely to experience flares during the early postpartum period than during pregnancy; however, flare rates in those with spondyloarthritis remain stable.

Seven cases of the ⁠Andes hantavirus have now been confirmed among people ⁠who were passengers on board the ⁠cruise ship, the ‌World Health Organization said on...

News All Time

Young Age, Lower BMI May Predict HIV Treatment Failure

Younger age, lower BMI for age, and lower CD4% at antiretroviral therapy initiation may predict treatment failure in children living with HIV.

California's Highest Court Leans Toward Gilead in Considering Drugmakers' 'duty to Innovate'

California's highest court on Wednesday appeared skeptical of requiring Gilead Sciences and other manufacturers of drugs that are considered safe to try developing drugs...

First Dual Flu-COVID Vaccine, mCombriax, Wins EU Approval

mCombriax demonstrates strong immunogenicity across age groups, exceeding comparator vaccines for multiple influenza strains and SARS-CoV-2 targets.

WHO Delays Pandemic Treaty Amid Pathogen-sharing Dispute

World Health Organization member states said on Friday they had extended talks on pathogen-sharing rules, ⁠casting doubt on when a pandemic treaty adopted last year can come...

Evacuations Planned as Suspected Hantavirus Outbreak Traps 150 on Ship Off Cape Verde

Medics were working on Monday to evacuate two people with symptoms of the deadly hantavirus after a suspected outbreak on a luxury cruise ship held off West Africa carrying...

The Unprecedented Rise of Scientists Fact-Checking the Feds

As trust in public health agencies erodes, researchers are finding themselves in an awkward new role — as fact-checkers of the federal government.

EU Regulator Forms Expert Group to Tackle Vaccine Hesitancy

The European Union's medicines regulator has set ⁠up a new group to advise on issues related ⁠to vaccine hesitancy and boost outreach initiatives.

Lancet Medical Journal Declined US Senate COVID Origins Ask

Leading medical journal The Lancet will decline a request to provide evidence for a ⁠U.S. Senate inquiry into the origins of the COVID-19 pandemic, its editor-in-chief...

Ghana Rejects Proposed US Health Aid Deal, Citing Data Concerns, Source Says

Ghana has rejected a bilateral health deal with the U.S., a source familiar with the negotiations told Reuters, the latest stumbling ⁠block to the Trump administration's...

WHO Global Alliance Delivers 100 M Child Vaccines Since 2023

More than 100 million vaccine doses have been delivered to millions of children since ⁠2023 under a global drive to reverse pandemic-related declines in childhood immunisation.

US Military No Longer Required to Get Flu Vaccine, Hegseth Says

The Pentagon will no longer require members of the U.S. military to get the ⁠flu vaccine, Defense Secretary Pete Hegseth said on Tuesday.

Moderna Starts Late-stage Trial of Bird Flu Vaccine in US, UK

Moderna said on Tuesday it had started a late-stage study of its experimental bird flu vaccine ⁠in the U.S. and the UK, marking the first time a pandemic bird flu vaccine...

The Long-COVID Crisis: No Cure, Little Attention

On International Long COVID Awareness Day, advocates warned that long COVID — affecting 400 million people — remains underrecognized by clinicians and underfunded.

Long COVID May Persist as Diagnostic Gaps Remain

Long COVID reflects persistent biological dysfunction with multisystem involvement, while gaps in biomarkers and treatment continue to complicate diagnosis and clinical care.

US CDC Will Not Publish Report Showing COVID Vaccine Effectiveness

A report showing the efficacy of COVID-19 vaccines has been blocked from being published in the U.S. ⁠Centers for Disease Control and Prevention's flagship scientific...

Deadly Meningitis Spreads as Sudanese Refugees Pack Chad Camps, MSF Says

Cases of deadly meningitis are surging in eastern Chad, killing ⁠nearly 12% of children who catch it in an area housing hundreds of thousands of ⁠war refugees from...

Recommended News For You

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

What does it mean for Biden's prostate cancer to be 'aggressive'? A urologic surgeon explains

The need for more Latinx participants in Alzheimer's trials is urgent.

Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer

In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

Recommended Articles For You

Intravenous Calcium for Reducing Blood Loss During Cesarean Delivery: A Review of Current Evidence 

Mastering Modern Oncology: Accreditation, Education, and Research Trends for 2025 

The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology 

All You Need To Know About Cancer Antigen 27-29: Causes, Symptoms & Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Interleukin-6 may boost prediction of obesity-related cancers

2.

Breast cancer screening in women's 40s can save lives, study says

3.

Higher levels of HIF2α found to slow down aggressive childhood cancer

4.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

5.

TULSA Is Effective in Long-Term Prostate Cancer Control.

1.

A New Perspective on Spherocytosis: Uncovering Innovative Treatments

2.

Understanding QSOFA: A Vital Tool for Recognizing Sepsis 

3.

Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights

4.

Stomach Cancer: Uncovering the Subtle Signs and Symptoms

5.

Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

2.

Navigating the Complexities of Ph Negative ALL - Part XI

3.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot